Department of Physical Medicine and Rehabilitation, Sisli Etfal Education and Research Hospital, Istanbul, Turkey.
Eur J Phys Rehabil Med. 2009 Dec;45(4):521-6. Epub 2009 Sep 23.
The purpose of this study was to develop a Turkish version of ECOS 16 Questionnaire and assess its reliability and validity.
Sixty four women with postmenopausal osteoporosis were included in the study. It was mandatory for all patients to be Turkish literate and without symptoms of dementia. Patients who were diagnosed as secondary osteoporosis by clinical and laboratory examinations were excluded from the study. After translation process, the Turkish version of the scale was applied to each participant twice with an interval of 2 weeks. For reliability study, internal consistency (Chronbach alpha) of ECOS 16 total score and test-retest intraclass correlation coefficient (ICC) were calculated. Validation study was assessed by correlating the scale with QUALEFFO 41.
The mean age at menopause and age of patients were 45.61+/-6.04 years and 59.91+/-8.69 years respectively. Chronbach alpha of the Turkish version of the ECOS 16 was 0.90. The test-retest reliability (ICC) of the Turkish version of the ECOS 16 was determined as 0.83 for the total score, and ranged between 0.72-0.88 for individual items. In terms of validity; the Turkish version of ECOS 16 correlated significantly with QUALEFFO 41 (r=0.844 P<0.0001).
. The Turkish version of the ECOS 16 is a reliable and valid questionnaire to be used in the evaluation of Turkish women with postmenopausal osteoporosis.
本研究旨在开发土耳其语版 ECOS 16 问卷，并评估其信度和效度。
本研究纳入了 64 名绝经后骨质疏松症女性患者。所有患者必须具有土耳其语读写能力且无痴呆症状。通过临床和实验室检查诊断为继发性骨质疏松症的患者被排除在研究之外。经过翻译过程后，每位参与者在两周的间隔内两次接受了该量表的土耳其语版本。为了进行信度研究，计算了 ECOS 16 总分的内部一致性（Chronbach alpha）和测试-重测组内相关系数（ICC）。验证研究通过将该量表与 QUALEFFO 41 相关联来评估。
绝经年龄和患者年龄的平均值分别为 45.61±6.04 岁和 59.91±8.69 岁。ECOS 16 土耳其语版本的 Cronbach alpha 为 0.90。ECOS 16 土耳其语版本的测试-重测信度（ICC）总分为 0.83，单项评分在 0.72-0.88 之间。在有效性方面；ECOS 16 土耳其语版本与 QUALEFFO 41 显著相关（r=0.844，P<0.0001）。
ECOS 16 土耳其语版本是一种可靠且有效的问卷，可用于评估土耳其绝经后骨质疏松症女性。
